lysyllysine has been researched along with vasoactive intestinal peptide in 1 studies
| Studies (lysyllysine) | Trials (lysyllysine) | Recent Studies (post-2010) (lysyllysine) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 50 | 0 | 16 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaggi, M; Mathur, A; Mukherjee, R; Prasad, S | 1 |
1 other study(ies) available for lysyllysine and vasoactive intestinal peptide
| Article | Year |
|---|---|
Delivering multiple anticancer peptides as a single prodrug using lysyl-lysine as a facile linker.
Topics: Amino Acid Sequence; Animals; Bombesin; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Dipeptides; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Sequence Data; Peptide Fragments; Prodrugs; Somatostatin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substance P; Vasoactive Intestinal Peptide; Xenograft Model Antitumor Assays | 2007 |